Key result
This editorial proposes a new diagnostic and management approach for patients with chronic coronary syndromes based on the ISCHEMIA trial results and pretest probability.
The ISCHEMIA trial results challenge current ESC guidelines for diagnosing stable angina, prompting a proposed new approach based on pretest probability.
0.34). The ISCHEMIA trial deeply disrupted many of our prior attitudes regarding management strategies for patients with stable coronary artery disease. The findings underscore the benefits of disease-modifying OMT for stable coronary artery disease patients. The main purposes of ischemia assessment before this trial were: Diagnostic purposes, assessment of outcome, and adding to decision-making processes. Obviously, this changed after the trial results. The results of ISCHEMIA might challenge the current diagnostic approach for stable angina patients recommended in the last European Society of Cardiology guidelines on chronic coronary disease that were based on studies published before the ISCHEMIA trial. In this editorial we propose our approach based on the ISCHEMIA study and the pretest probability for a positive test in patients with chronic coronary syndromes.
No takes yet. Share an insight, caveat, or question.
Vidal-Pérez et al. (2021) conducted an editorial in Stable coronary artery disease. Disease-modifying optimal medical therapy (OMT) was evaluated. This editorial proposes a new diagnostic and management approach for patients with chronic coronary syndromes based on the ISCHEMIA trial results and pretest probability.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: